Commonwealth of Pennsylvania Public School Employees Retirement System’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
31,255
-2,368
-7% -$96.9K 0.01% 928
2026
Q1
$1.12M Sell
33,623
-37
-0.1% -$1.1K 0.01% 1061
2025
Q4
$1M Sell
33,660
-895
-3% -$29.2K 0.01% 1113
2025
Q3
$1.25M Sell
34,555
-387,523
-92% -$12.8M 0.01% 1018
2025
Q2
$5.19M Buy
422,078
+390,137
+1,221% +$14.5M 0.03% 439
2025
Q1
$1.26M Buy
31,941
+3,447
+12% +$116K 0.01% 930
2024
Q4
$858K Sell
28,494
-22
-0.1% -$631 0.01% 1059
2024
Q3
$667K Buy
+28,516
New +$623K ﹤0.01% 1140

Other funds holding TGTX

Commonwealth of Pennsylvania Public School Employees Retirement System's TGTX Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its TG Therapeutics (TGTX) stake by 7% in Q2 2026, selling an estimated $96.9K and leaving 31,255 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #928.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.19M in Q2 2025. 279 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Commonwealth of Pennsylvania Public School Employees Retirement System held 31,255 shares of TG Therapeutics worth $1.72M as of Q2 2026.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 2,368 TG Therapeutics shares in Q2 2026, an estimated $96.9K.
  • TG Therapeutics made up 0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #928 holding.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's TG Therapeutics position peaked at $5.19M in Q2 2025.
  • 279 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.